Total Payments
$3,228
2024 Payments
$578.15
Companies
35
Transactions
150
Medicare Patients
7,929
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$2,928 (90.7%)
Education$299.85 (9.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,928 | 147 | 90.7% |
| Education | $299.85 | 3 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,058 | 55 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $207.20 | 12 | $0 (2024) |
| AbbVie Inc. | $204.46 | 9 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $161.69 | 4 | $0 (2024) |
| Boston Scientific Corporation | $135.63 | 1 | $0 (2022) |
| EVOKE PHARMA, INC. | $125.00 | 1 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $125.00 | 1 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $124.23 | 9 | $0 (2022) |
| Abbott Laboratories | $118.19 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $107.17 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $578.15 | 26 | Phathom Pharmaceuticals, Inc. ($161.69) |
| 2023 | $317.29 | 20 | Janssen Biotech, Inc. ($223.47) |
| 2022 | $637.97 | 23 | Janssen Biotech, Inc. ($226.95) |
| 2021 | $606.15 | 23 | Janssen Biotech, Inc. ($282.88) |
| 2020 | $144.34 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($53.82) |
| 2019 | $368.64 | 13 | Abbott Laboratories ($118.19) |
| 2018 | $267.69 | 18 | Janssen Biotech, Inc. ($39.10) |
| 2017 | $307.51 | 16 | Janssen Biotech, Inc. ($127.95) |
All Payment Transactions
150 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: LIVER DISEASE | ||||||
| 12/03/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Immunology | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/28/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $113.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/02/2024 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $38.39 | General |
| 07/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.40 | General |
| Category: Neuroscience | ||||||
| 06/19/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 06/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/11/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Immunology | ||||||
| 05/15/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Immunology | ||||||
| 05/10/2024 | Olympus America Inc. | EVIS EXERA III COLONOVIDEOSCOPE (Device) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Gastroenterology | ||||||
| 05/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/17/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 04/03/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Immunology | ||||||
| 02/28/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 02/16/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/07/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,993 | 3,059 | $499,001 | $353,864 |
| 2022 | 16 | 2,209 | 3,322 | $528,488 | $355,343 |
| 2021 | 13 | 1,946 | 2,729 | $436,244 | $299,687 |
| 2020 | 14 | 1,781 | 2,467 | $410,266 | $290,202 |
Total Patients
7,929
Total Services
11,577
Medicare Billing
$1.3M
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 643 | 1,406 | $192,046 | $143,677 | 74.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 228 | 228 | $53,889 | $38,678 | 71.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 204 | 225 | $42,618 | $30,992 | 72.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 115 | 115 | $33,395 | $24,484 | 73.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 77 | 242 | $29,694 | $23,249 | 78.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 237 | 267 | $42,299 | $21,827 | 51.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 94 | 95 | $19,900 | $14,297 | 71.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 76 | 90 | $19,483 | $12,799 | 65.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 144 | $13,641 | $10,008 | 73.4% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 11 | 11 | $11,064 | $7,277 | 65.8% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 39 | 42 | $9,207 | $6,778 | 73.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 85 | $6,973 | $5,465 | 78.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 43 | 43 | $9,625 | $5,292 | 55.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 31 | 33 | $6,912 | $3,883 | 56.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 18 | 20 | $5,777 | $3,541 | 61.3% |
| 44361 | Biopsy of small bowel (except ileum) using an endoscope | Facility | 2023 | 12 | 13 | $2,477 | $1,615 | 65.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 628 | 1,281 | $150,440 | $109,311 | 72.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 263 | 263 | $59,019 | $40,269 | 68.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 103 | 419 | $46,832 | $35,919 | 76.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 169 | 170 | $59,651 | $34,707 | 58.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 254 | 285 | $47,890 | $24,545 | 51.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 112 | 131 | $28,468 | $21,091 | 74.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 167 | 175 | $27,644 | $18,716 | 67.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 233 | 270 | $21,514 | $16,077 | 74.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 96 | 96 | $23,913 | $14,309 | 59.8% |
About Dr. Paul Demartino, MD
Dr. Paul Demartino, MD is a Gastroenterology healthcare provider based in Toms River, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922104827.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Demartino, MD has received a total of $3,228 in payments from pharmaceutical and medical device companies, with $578.15 received in 2024. These payments were reported across 150 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,928).
As a Medicare-enrolled provider, Demartino has provided services to 7,929 Medicare beneficiaries, totaling 11,577 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Toms River, NJ
- Active Since 09/16/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1922104827
Products in Payments
- STELARA (Biological) $915.17
- REMICADE (Biological) $233.67
- OCALIVA (Drug) $178.07
- VOQUEZNA (Drug) $161.69
- General - Pain Management (Device) $135.63
- GIMOTI (Drug) $125.00
- XIFAXAN (Drug) $124.23
- LINZESS (Drug) $94.42
- DUPIXENT (Biological) $83.70
- XELJANZ (Drug) $73.82
- ZEPOSIA (Drug) $70.68
- GATTEX (Drug) $66.41
- INTERSTIM (Device) $62.56
- ENTYVIO (Biological) $52.63
- Entyvio (Biological) $51.52
- ZENPEP (Drug) $40.20
- TREMFYA (Drug) $34.03
- RESMETIROM (Drug) $33.87
- Donnatal (Drug) $30.24
- DIFICID (Drug) $29.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Toms River
Mr. Neil Nagaria, Md, MD
Gastroenterology — Payments: $18,349
Gastroenterology $18,349
Teresa Tacopina, Md, MD
Gastroenterology — Payments: $7,735
Gastroenterology $7,735
Dr. Eric Eschinger, Md, MD
Gastroenterology — Payments: $6,236
Gastroenterology $6,236
Kenneth Glazier
Gastroenterology — Payments: $5,912
Gastroenterology $5,912
Carl Raso, Md, MD
Gastroenterology — Payments: $5,227
Gastroenterology $5,227
Gabrielle Corpuz, Pa-C, PA-C
Gastroenterology — Payments: $4,258
Gastroenterology $4,258